Floatz logo

Velaglucerase Alfa

Gaucher Disease Type III

Shireprotein_peptidePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Gaucher Disease Type III cohort.

Asset / SponsorPhaseRating
Elelyso
Ari Zimran
Phase 4BB
.ALPHA.-D-GLUCOSYL-N-ACYLSPHINGOSINE GLUCOHYDROLASE
Sanofi
Phase 3BB
Eliglustat
Sanofi
Phase 3BB
Venglustat
Sanofi
Phase 3B
Arimoclomol
ZevraDenmark
Phase 2CCC

View all 9 →

Same molecule, other indications

Velaglucerase Alfa is also rated in:

Gaucher diseaseActive
A
Indicative · Phase 4
83 / 100
View asset →
diseaseDormant
BB
Indicative · Phase 4
69 / 100
View asset →
Gaucher disease type IDormant
BB
Indicative · Phase 4
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →